ARDELYX, INC. Amortization of Debt Issuance Costs
ARDELYX, INC. (ARDX) reported Amortization of Debt Issuance Costs of $226.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2022-08-04
- ARDELYX, INC. amortization of debt issuance costs for the quarter ending 2022-06-30 was $57.00K, a 64.15% decline year-over-year.
- ARDELYX, INC. amortization of debt issuance costs for the quarter ending 2022-03-31 was $169.00K, a 7.64% increase year-over-year.
- ARDELYX, INC. amortization of debt issuance costs for the quarter ending 2021-12-31 was $161.00K, a 101.25% increase year-over-year.
- ARDELYX, INC. amortization of debt issuance costs for the quarter ending 2021-09-30 was $161.00K, a 20.15% increase year-over-year.
- ARDELYX, INC. amortization of debt issuance costs for fiscal 2021 was $638.00K, a 28.63% increase from fiscal 2020.
- ARDELYX, INC. amortization of debt issuance costs for fiscal 2020 was $496.00K, a 25.97% decline from fiscal 2019.
- ARDELYX, INC. amortization of debt issuance costs for fiscal 2019 was $670.00K, a 183.90% increase from fiscal 2018.
- ARDELYX, INC. amortization of debt issuance costs for fiscal 2018 was $236.00K, a 37.07% decline from fiscal 2017.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $226.00K 10-Q · filed 2022-08-04 | $387.00K derived: sum of 3 quarters · filed 2022-08-04 | $548.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | $169.00K 10-Q · filed 2022-05-05 | $330.00K derived: sum of 2 quarters · filed 2022-05-05 | $491.00K derived: sum of 3 quarters · filed 2022-05-05 | $650.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $322.00K derived: sum of 2 quarters · filed 2022-02-28 | $481.00K derived: sum of 3 quarters · filed 2022-08-04 | $638.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $320.00K derived: sum of 2 quarters · filed 2022-08-04 | $477.00K 10-Q · filed 2021-11-12 | $557.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-06-30 | $159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $316.00K 10-Q · filed 2022-08-04 | $396.00K derived: sum of 3 quarters · filed 2022-08-04 | $530.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $157.00K 10-Q · filed 2022-05-05 | $237.00K derived: sum of 2 quarters · filed 2022-05-05 | $371.00K derived: sum of 3 quarters · filed 2022-05-05 | $541.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $214.00K derived: sum of 2 quarters · filed 2022-02-28 | $384.00K derived: sum of 3 quarters · filed 2022-02-28 | $496.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $304.00K derived: sum of 2 quarters · filed 2021-11-12 | $416.00K 10-Q · filed 2021-11-12 | $536.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $282.00K 10-Q · filed 2021-08-13 | $402.00K derived: sum of 3 quarters · filed 2022-02-28 | $670.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $112.00K 10-Q · filed 2021-05-06 | $232.00K derived: sum of 2 quarters · filed 2022-02-28 | $500.00K derived: sum of 3 quarters · filed 2022-02-28 | $662.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $388.00K derived: sum of 2 quarters · filed 2022-02-28 | $550.00K derived: sum of 3 quarters · filed 2022-02-28 | $670.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $430.00K derived: sum of 2 quarters · filed 2020-11-05 | $550.00K 10-Q · filed 2020-11-05 | $642.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $282.00K 10-Q · filed 2020-08-06 | $374.00K derived: sum of 3 quarters · filed 2021-03-08 | $459.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $120.00K 10-Q · filed 2020-05-07 | $212.00K derived: sum of 2 quarters · filed 2021-03-08 | $297.00K derived: sum of 3 quarters · filed 2021-03-08 | $342.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $177.00K derived: sum of 2 quarters · filed 2021-03-08 | $222.00K derived: sum of 3 quarters · filed 2021-03-08 | $236.00K 10-K · filed 2021-03-08 |
| 2018-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $130.00K derived: sum of 2 quarters · filed 2019-11-06 | $144.00K 10-Q · filed 2019-11-06 | $159.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $59.00K 10-Q · filed 2019-08-09 | $74.00K derived: sum of 3 quarters · filed 2020-03-06 | $109.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-03-31 | $14.00K 10-Q · filed 2019-05-07 | $29.00K derived: sum of 2 quarters · filed 2020-03-06 | $64.00K derived: sum of 3 quarters · filed 2020-03-06 | $317.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2017-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $50.00K derived: sum of 2 quarters · filed 2020-03-06 | $303.00K derived: sum of 3 quarters · filed 2020-03-06 | $375.00K 10-K · filed 2020-03-06 |
| 2017-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $288.00K derived: sum of 2 quarters · filed 2018-11-07 | $360.00K 10-Q · filed 2018-11-07 | $417.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $325.00K 10-Q · filed 2018-08-07 | $382.00K derived: sum of 3 quarters · filed 2019-03-06 | $497.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $72.00K 10-Q · filed 2018-05-08 | $129.00K derived: sum of 2 quarters · filed 2019-03-06 | $244.00K derived: sum of 3 quarters · filed 2019-03-06 | $338.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $172.00K derived: sum of 2 quarters · filed 2019-03-06 | $266.00K derived: sum of 3 quarters · filed 2019-03-06 | $346.00K 10-K · filed 2019-03-06 |
| 2016-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $209.00K derived: sum of 2 quarters · filed 2017-11-07 | $289.00K 10-Q · filed 2017-11-07 | $552.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $174.00K 10-Q · filed 2017-08-09 | $437.00K derived: sum of 3 quarters · filed 2018-03-14 | |
| 2016-03-31 | $80.00K 10-Q · filed 2017-05-05 | $343.00K derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2015-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $351.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $88.00K 10-Q · filed 2016-11-07 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |